Polysaccharides as Nanomaterials for Therapeutics - Harnessing Biomaterials in Nanomedicine: Preparation, Toxicity, and Applications - page 153

39. Ataullakhanov RI, Ataullakhanov FI, Abdullaev DM (1984) Increase
in the permeability of the lymphocyte plasma membrane for uni- and
bivalent cations and low-molecular metabolites following exposure to
mitogenic polyanions. Biull Eksp Biol Med 98: 81-84.
40. Sallas F, Darcy R (2008) Amphiphilic cyclodextrins — advances in
synthesis and supramolecular chemistry. Eur J Org Chem 6: 957-969.
41. Szejtli J (1998) Introduction and general overview of cyclodextrin
chemistry. Chem Rev 98: 1743-1754.
42. Hu-Lieskovan S, Heidel JD, Bartlett DW, Davis ME, Triche TJ (2005)
Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral
delivery of small interfering RNA inhibits tumor growth in a murine
model of metastatic Ewing's sarcoma. Cancer Res 65: 8984-8992.
43. Davis ME, Brewster ME (2004) Cyclodextrin-based pharmaceutics:
past, present and future. Nat Rev Drug Discov 3: 1023-1035.
44. Falk R, Domb AJ, Polacheck I (1999) A novel injectable water-soluble
amphotericin B-arabinogalactan conjugate. Antimicrob Agents
Chemother 43: 1975-1981.
45. Leathers TD (2003) Biotechnological production and applications of
pullulan. Appl Microbiol Biotechnol 62: 468-473.
46. Linhardt RJ (2003) 2003 Claude S. Hudson Award address in
carbohydrate chemistry. Heparin: structure and activity. J Med Chem
46: 2551-2564.
47. Kemp MM, Linhardt RJ (2010) Heparin-based nanoparticles. Wiley
Interdiscip Rev Nanomed Nanobiotechnol 2: 77-87.
48. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, et al. (2004) Structure and
interactions in covalently and ionically crosslinked chitosan hydrogels
for biomedical applications. Eur J Pharm Biopharm 57: 19-34.
49. Berger J, Reist M, Mayer JM, Felt O, Gurny R (2004) Structure and
interactions in chitosan hydrogels formed by complexation or
aggregation for biomedical applications. Eur J Pharm Biopharm 57:
35-52.
50. Ohya Y, Shiratani M, Kobayashi H, Ouchi T (1994) Release behavior
of 5-fluorouracil from chitosan-gel nanospheres immobilizing
5-fluorouracil coated with polysaccharides and their cell-specific
cytotoxicity. J Macromol Sci Pure Appl Chem A31: 629-642.
51. Banerjee T, Mitra S, Kumar Singh A, Kumar Sharma R, Maitra A (2002)
Preparation, characterization and biodistribution of ultrafine chitosan
nanoparticles. Int J Pharm 243: 93-105.
52. Bodnar M, Hartmann JF, Borbely J (2005) Preparation and
characterization of chitosan-based nanoparticles. Biomacromolecules
6: 2521-2527.